Back to DE D. E. Shaw & Co., Inc.

KROSKROS
Showing 8 of 17 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in KEROS THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 267,460 shares of KROS (KEROS THERAPEUTICS INC), worth $2.9M as of 2026-Q2. The position was decreased (-47.5% shares). KROS represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$2.9M

Current Shares

267,460

Total Value Change

-$8M

Total Shares Change

+81,172

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
267,460
-47.5%
$2.9M0.0%$10.70
0
2026-Q1
Decreased
509,608
-32.5%
$5.6M0.0%$13.40
0
2025-Q4
Decreased
755,473
-43.3%
$15.4M0.0%$20.27
0
2025-Q3
Increased
1.3M
+2.6%
$21.1M0.0%$15.95
29
2025-Q2
Increased
1.3M
+2.7%
$17.3M0.0%$13.49
29
2025-Q1
Increased
1.3M
+103x
$12.9M0.0%$10.79
45
2024-Q4
Decreased
12,099
-93.5%
$191,5270.0%$15.64
0
2024-Q3
Increased
186,288
+6.0%
$10.8M0.0%$56.45
29

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used